Early Access Care

Early Access Care provides consultative, functional and operational support to biopharmaceutical companies for Expanded Access and Compassionate Use. Our Mission is to accelerate access of investigational drugs to patients in need. EAC manages single-patient requests (called single-patient INDs) and multi-patient expanded access protocols (EAPs). EAC provides a single point of reference for all physician inquiries to your company and functional support across the entire request process: assisting the physician and biopharmaceutical company in managing the request and approval, tracking the request and all required elements, providing education on proper handling of the investigational drug, and verifying that the investigational drug is received by the physician. We help patients and their physicians work through the process of requesting compassionate use investigational drugs. Use EAC to manage your compassionate use requests freeing your internal resources to focus upon drug development – advancing your filing and approval. We are experts in Expanded Access / Compassionate Use and are ready to help your company.